coptisine has been researched along with Diabetic Nephropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M; Li, X; Li, Z; Ma, L; Ma, Z; Zhai, J; Zhang, H; Zhang, Y; Zou, J | 1 |
1 other study(ies) available for coptisine and Diabetic Nephropathies
| Article | Year |
|---|---|
Coptisine ameliorates renal injury in diabetic rats through the activation of Nrf2 signaling pathway.
Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Heme Oxygenase (Decyclizing); Kidney; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Protective Agents; Rats, Sprague-Dawley; Signal Transduction | 2020 |